Global Circle Acute Ischemic Stroke Market

Circle Acute Ischemic Stroke Comprehensive Study by Type (Thrombotic Ischemic Stroke, Embolic Ischemic Stroke), Treatment (Thrombolytic Therapeutics, Antihypertensive Therapeutics, Antiplatelet Therapeutics, Anticoagulants), End-users (Hospitals, Ambulatory Surgical Center, Diagnostic Centers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Players and Region - Global Market Outlook to 2028

Circle Acute Ischemic Stroke Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Circle Acute Ischemic Stroke Market?

Ischemic stroke is one of three types of stroke characterized by the sudden loss of blood circulation to an area of the brain, resulting in a corresponding loss of neurologic function. Acute ischemic stroke is caused by thrombotic or embolic occlusion of a cerebral artery. It is more common than hemorrhagic stroke. The factors such as Increased Prevalence of Acute Ischemic Stroke and Rise in the Number of Diagnostic Centers and Hospitals are driving the global acute ischemic stroke market

Highlights from Circle Acute Ischemic Stroke Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledAbbott Laboratories (United States), Medtronic plc (Ireland), Boston Scientific Corporation (United States), Cordis Corporation (United States), Koninklijke Philips N.V. (Netherlands), GE Healthcare (United States), Siemens AG (Germany), Stryker Corporation (United States), Genentech, Inc. (United States) and Merck & Co., Inc. (United States)


The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Circle Acute Ischemic Stroke market throughout the forecasted period.

Abbott Laboratories (United States), Medtronic plc (Ireland), Boston Scientific Corporation (United States), Cordis Corporation (United States), Koninklijke Philips N.V. (Netherlands), GE Healthcare (United States), Siemens AG (Germany), Stryker Corporation (United States), Genentech, Inc. (United States) and Merck & Co., Inc. (United States) are some of the key players profiled in the study.

Circle Acute Ischemic Stroke Market Segmentation:
ScopeSub-Segments
TypeThrombotic Ischemic Stroke and Embolic Ischemic Stroke
TreatmentThrombolytic Therapeutics,Antihypertensive Therapeutics,Antiplatelet Therapeutics,Anticoagulants
End-usersHospitals,Ambulatory Surgical Center,Diagnostic Centers
Distribution ChannelRetail Pharmacies,Hospital Pharmacies,Online Pharmacies


On the basis of geography, the market of Circle Acute Ischemic Stroke has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increased Number of Research and Development Activities and Growing Number of Online Pharmacies

Market Growth Drivers:
Increased Prevalence of Acute Ischemic Stroke and Rise in the Number of Diagnostic Centers and Hospitals

Challenges:
Stringent Government Rules and Regulations

Restraints:
Side Effects of the Medications and High Research and Development Investment

Opportunities:
Growth in the Healthcare Industry and Huge Investment by Major Players

Key Target Audience
Acute Ischemic Stroke Treatment Providers, Research Professionals, Emerging Companies and End-users

In 2021, Abbott launched Amplatzer Amulet Left Atrial Appendage Occluder to treat people with atrial fibrillation (AFib) who are at risk of ischemic stroke. The device provides prompt closure of the left atrial appendage (LAA), which lowers stroke risk and eliminates the immediate requirement for blood-thinning medicines in persons with AFib.


Report Objectives / Segmentation Covered

By Type
  • Thrombotic Ischemic Stroke
  • Embolic Ischemic Stroke
By Treatment
  • Thrombolytic Therapeutics
  • Antihypertensive Therapeutics
  • Antiplatelet Therapeutics
  • Anticoagulants

By End-users
  • Hospitals
  • Ambulatory Surgical Center
  • Diagnostic Centers

By Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Acute Ischemic Stroke
      • 3.2.2. Rise in the Number of Diagnostic Centers and Hospitals
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increased Number of Research and Development Activities
      • 3.4.2. Growing Number of Online Pharmacies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Circle Acute Ischemic Stroke, by Type, Treatment, End-users, Distribution Channel and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Circle Acute Ischemic Stroke (Value)
      • 5.2.1. Global Circle Acute Ischemic Stroke by: Type (Value)
        • 5.2.1.1. Thrombotic Ischemic Stroke
        • 5.2.1.2. Embolic Ischemic Stroke
      • 5.2.2. Global Circle Acute Ischemic Stroke by: Treatment (Value)
        • 5.2.2.1. Thrombolytic Therapeutics
        • 5.2.2.2. Antihypertensive Therapeutics
        • 5.2.2.3. Antiplatelet Therapeutics
        • 5.2.2.4. Anticoagulants
      • 5.2.3. Global Circle Acute Ischemic Stroke by: End-users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory Surgical Center
        • 5.2.3.3. Diagnostic Centers
      • 5.2.4. Global Circle Acute Ischemic Stroke by: Distribution Channel (Value)
        • 5.2.4.1. Retail Pharmacies
        • 5.2.4.2. Hospital Pharmacies
        • 5.2.4.3. Online Pharmacies
      • 5.2.5. Global Circle Acute Ischemic Stroke Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Circle Acute Ischemic Stroke: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic plc (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Boston Scientific Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cordis Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Koninklijke Philips N.V. (Netherlands)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GE Healthcare (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Siemens AG (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Stryker Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Genentech, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Merck & Co., Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Circle Acute Ischemic Stroke Sale, by Type, Treatment, End-users, Distribution Channel and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Circle Acute Ischemic Stroke (Value)
      • 7.2.1. Global Circle Acute Ischemic Stroke by: Type (Value)
        • 7.2.1.1. Thrombotic Ischemic Stroke
        • 7.2.1.2. Embolic Ischemic Stroke
      • 7.2.2. Global Circle Acute Ischemic Stroke by: Treatment (Value)
        • 7.2.2.1. Thrombolytic Therapeutics
        • 7.2.2.2. Antihypertensive Therapeutics
        • 7.2.2.3. Antiplatelet Therapeutics
        • 7.2.2.4. Anticoagulants
      • 7.2.3. Global Circle Acute Ischemic Stroke by: End-users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory Surgical Center
        • 7.2.3.3. Diagnostic Centers
      • 7.2.4. Global Circle Acute Ischemic Stroke by: Distribution Channel (Value)
        • 7.2.4.1. Retail Pharmacies
        • 7.2.4.2. Hospital Pharmacies
        • 7.2.4.3. Online Pharmacies
      • 7.2.5. Global Circle Acute Ischemic Stroke Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Circle Acute Ischemic Stroke: by Type(USD Million)
  • Table 2. Circle Acute Ischemic Stroke Thrombotic Ischemic Stroke , by Region USD Million (2017-2022)
  • Table 3. Circle Acute Ischemic Stroke Embolic Ischemic Stroke , by Region USD Million (2017-2022)
  • Table 4. Circle Acute Ischemic Stroke: by Treatment(USD Million)
  • Table 5. Circle Acute Ischemic Stroke Thrombolytic Therapeutics , by Region USD Million (2017-2022)
  • Table 6. Circle Acute Ischemic Stroke Antihypertensive Therapeutics , by Region USD Million (2017-2022)
  • Table 7. Circle Acute Ischemic Stroke Antiplatelet Therapeutics , by Region USD Million (2017-2022)
  • Table 8. Circle Acute Ischemic Stroke Anticoagulants , by Region USD Million (2017-2022)
  • Table 9. Circle Acute Ischemic Stroke: by End-users(USD Million)
  • Table 10. Circle Acute Ischemic Stroke Hospitals , by Region USD Million (2017-2022)
  • Table 11. Circle Acute Ischemic Stroke Ambulatory Surgical Center , by Region USD Million (2017-2022)
  • Table 12. Circle Acute Ischemic Stroke Diagnostic Centers , by Region USD Million (2017-2022)
  • Table 13. Circle Acute Ischemic Stroke: by Distribution Channel(USD Million)
  • Table 14. Circle Acute Ischemic Stroke Retail Pharmacies , by Region USD Million (2017-2022)
  • Table 15. Circle Acute Ischemic Stroke Hospital Pharmacies , by Region USD Million (2017-2022)
  • Table 16. Circle Acute Ischemic Stroke Online Pharmacies , by Region USD Million (2017-2022)
  • Table 17. South America Circle Acute Ischemic Stroke, by Country USD Million (2017-2022)
  • Table 18. South America Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 19. South America Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 20. South America Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 21. South America Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 22. Brazil Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 23. Brazil Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 24. Brazil Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 25. Brazil Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 26. Argentina Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 27. Argentina Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 28. Argentina Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 29. Argentina Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 30. Rest of South America Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 31. Rest of South America Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 32. Rest of South America Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 33. Rest of South America Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 34. Asia Pacific Circle Acute Ischemic Stroke, by Country USD Million (2017-2022)
  • Table 35. Asia Pacific Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 36. Asia Pacific Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 37. Asia Pacific Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 38. Asia Pacific Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 39. China Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 40. China Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 41. China Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 42. China Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 43. Japan Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 44. Japan Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 45. Japan Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 46. Japan Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 47. India Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 48. India Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 49. India Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 50. India Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 51. South Korea Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 52. South Korea Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 53. South Korea Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 54. South Korea Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 55. Taiwan Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 56. Taiwan Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 57. Taiwan Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 58. Taiwan Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 59. Australia Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 60. Australia Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 61. Australia Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 62. Australia Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 66. Rest of Asia-Pacific Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 67. Europe Circle Acute Ischemic Stroke, by Country USD Million (2017-2022)
  • Table 68. Europe Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 69. Europe Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 70. Europe Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 71. Europe Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 72. Germany Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 73. Germany Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 74. Germany Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 75. Germany Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 76. France Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 77. France Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 78. France Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 79. France Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 80. Italy Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 81. Italy Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 82. Italy Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 83. Italy Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 84. United Kingdom Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 85. United Kingdom Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 86. United Kingdom Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 87. United Kingdom Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 88. Netherlands Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 89. Netherlands Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 90. Netherlands Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 91. Netherlands Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 92. Rest of Europe Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 93. Rest of Europe Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 94. Rest of Europe Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 95. Rest of Europe Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 96. MEA Circle Acute Ischemic Stroke, by Country USD Million (2017-2022)
  • Table 97. MEA Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 98. MEA Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 99. MEA Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 100. MEA Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 101. Middle East Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 102. Middle East Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 103. Middle East Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 104. Middle East Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 105. Africa Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 106. Africa Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 107. Africa Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 108. Africa Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 109. North America Circle Acute Ischemic Stroke, by Country USD Million (2017-2022)
  • Table 110. North America Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 111. North America Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 112. North America Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 113. North America Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 114. United States Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 115. United States Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 116. United States Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 117. United States Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 118. Canada Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 119. Canada Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 120. Canada Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 121. Canada Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 122. Mexico Circle Acute Ischemic Stroke, by Type USD Million (2017-2022)
  • Table 123. Mexico Circle Acute Ischemic Stroke, by Treatment USD Million (2017-2022)
  • Table 124. Mexico Circle Acute Ischemic Stroke, by End-users USD Million (2017-2022)
  • Table 125. Mexico Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2017-2022)
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Circle Acute Ischemic Stroke: by Type(USD Million)
  • Table 137. Circle Acute Ischemic Stroke Thrombotic Ischemic Stroke , by Region USD Million (2023-2028)
  • Table 138. Circle Acute Ischemic Stroke Embolic Ischemic Stroke , by Region USD Million (2023-2028)
  • Table 139. Circle Acute Ischemic Stroke: by Treatment(USD Million)
  • Table 140. Circle Acute Ischemic Stroke Thrombolytic Therapeutics , by Region USD Million (2023-2028)
  • Table 141. Circle Acute Ischemic Stroke Antihypertensive Therapeutics , by Region USD Million (2023-2028)
  • Table 142. Circle Acute Ischemic Stroke Antiplatelet Therapeutics , by Region USD Million (2023-2028)
  • Table 143. Circle Acute Ischemic Stroke Anticoagulants , by Region USD Million (2023-2028)
  • Table 144. Circle Acute Ischemic Stroke: by End-users(USD Million)
  • Table 145. Circle Acute Ischemic Stroke Hospitals , by Region USD Million (2023-2028)
  • Table 146. Circle Acute Ischemic Stroke Ambulatory Surgical Center , by Region USD Million (2023-2028)
  • Table 147. Circle Acute Ischemic Stroke Diagnostic Centers , by Region USD Million (2023-2028)
  • Table 148. Circle Acute Ischemic Stroke: by Distribution Channel(USD Million)
  • Table 149. Circle Acute Ischemic Stroke Retail Pharmacies , by Region USD Million (2023-2028)
  • Table 150. Circle Acute Ischemic Stroke Hospital Pharmacies , by Region USD Million (2023-2028)
  • Table 151. Circle Acute Ischemic Stroke Online Pharmacies , by Region USD Million (2023-2028)
  • Table 152. South America Circle Acute Ischemic Stroke, by Country USD Million (2023-2028)
  • Table 153. South America Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 154. South America Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 155. South America Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 156. South America Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 157. Brazil Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 158. Brazil Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 159. Brazil Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 160. Brazil Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 161. Argentina Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 162. Argentina Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 163. Argentina Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 164. Argentina Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 165. Rest of South America Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 166. Rest of South America Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 167. Rest of South America Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 168. Rest of South America Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 169. Asia Pacific Circle Acute Ischemic Stroke, by Country USD Million (2023-2028)
  • Table 170. Asia Pacific Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 171. Asia Pacific Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 172. Asia Pacific Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 173. Asia Pacific Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 174. China Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 175. China Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 176. China Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 177. China Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 178. Japan Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 179. Japan Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 180. Japan Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 181. Japan Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 182. India Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 183. India Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 184. India Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 185. India Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 186. South Korea Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 187. South Korea Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 188. South Korea Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 189. South Korea Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 190. Taiwan Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 191. Taiwan Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 192. Taiwan Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 193. Taiwan Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 194. Australia Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 195. Australia Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 196. Australia Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 197. Australia Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 198. Rest of Asia-Pacific Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 199. Rest of Asia-Pacific Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 200. Rest of Asia-Pacific Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 201. Rest of Asia-Pacific Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 202. Europe Circle Acute Ischemic Stroke, by Country USD Million (2023-2028)
  • Table 203. Europe Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 204. Europe Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 205. Europe Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 206. Europe Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 207. Germany Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 208. Germany Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 209. Germany Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 210. Germany Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 211. France Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 212. France Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 213. France Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 214. France Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 215. Italy Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 216. Italy Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 217. Italy Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 218. Italy Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 219. United Kingdom Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 220. United Kingdom Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 221. United Kingdom Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 222. United Kingdom Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 223. Netherlands Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 224. Netherlands Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 225. Netherlands Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 226. Netherlands Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 227. Rest of Europe Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 228. Rest of Europe Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 229. Rest of Europe Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 230. Rest of Europe Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 231. MEA Circle Acute Ischemic Stroke, by Country USD Million (2023-2028)
  • Table 232. MEA Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 233. MEA Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 234. MEA Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 235. MEA Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 236. Middle East Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 237. Middle East Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 238. Middle East Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 239. Middle East Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 240. Africa Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 241. Africa Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 242. Africa Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 243. Africa Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 244. North America Circle Acute Ischemic Stroke, by Country USD Million (2023-2028)
  • Table 245. North America Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 246. North America Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 247. North America Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 248. North America Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 249. United States Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 250. United States Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 251. United States Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 252. United States Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 253. Canada Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 254. Canada Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 255. Canada Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 256. Canada Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 257. Mexico Circle Acute Ischemic Stroke, by Type USD Million (2023-2028)
  • Table 258. Mexico Circle Acute Ischemic Stroke, by Treatment USD Million (2023-2028)
  • Table 259. Mexico Circle Acute Ischemic Stroke, by End-users USD Million (2023-2028)
  • Table 260. Mexico Circle Acute Ischemic Stroke, by Distribution Channel USD Million (2023-2028)
  • Table 261. Research Programs/Design for This Report
  • Table 262. Key Data Information from Secondary Sources
  • Table 263. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Circle Acute Ischemic Stroke: by Type USD Million (2017-2022)
  • Figure 5. Global Circle Acute Ischemic Stroke: by Treatment USD Million (2017-2022)
  • Figure 6. Global Circle Acute Ischemic Stroke: by End-users USD Million (2017-2022)
  • Figure 7. Global Circle Acute Ischemic Stroke: by Distribution Channel USD Million (2017-2022)
  • Figure 8. South America Circle Acute Ischemic Stroke Share (%), by Country
  • Figure 9. Asia Pacific Circle Acute Ischemic Stroke Share (%), by Country
  • Figure 10. Europe Circle Acute Ischemic Stroke Share (%), by Country
  • Figure 11. MEA Circle Acute Ischemic Stroke Share (%), by Country
  • Figure 12. North America Circle Acute Ischemic Stroke Share (%), by Country
  • Figure 13. Global Circle Acute Ischemic Stroke share by Players 2022 (%)
  • Figure 14. Global Circle Acute Ischemic Stroke share by Players (Top 3) 2022(%)
  • Figure 15. Global Circle Acute Ischemic Stroke share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 19. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 20. Medtronic plc (Ireland) Revenue: by Geography 2022
  • Figure 21. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Boston Scientific Corporation (United States) Revenue: by Geography 2022
  • Figure 23. Cordis Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. Cordis Corporation (United States) Revenue: by Geography 2022
  • Figure 25. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 26. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2022
  • Figure 27. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 28. GE Healthcare (United States) Revenue: by Geography 2022
  • Figure 29. Siemens AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Siemens AG (Germany) Revenue: by Geography 2022
  • Figure 31. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Stryker Corporation (United States) Revenue: by Geography 2022
  • Figure 33. Genentech, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Genentech, Inc. (United States) Revenue: by Geography 2022
  • Figure 35. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Merck & Co., Inc. (United States) Revenue: by Geography 2022
  • Figure 37. Global Circle Acute Ischemic Stroke: by Type USD Million (2023-2028)
  • Figure 38. Global Circle Acute Ischemic Stroke: by Treatment USD Million (2023-2028)
  • Figure 39. Global Circle Acute Ischemic Stroke: by End-users USD Million (2023-2028)
  • Figure 40. Global Circle Acute Ischemic Stroke: by Distribution Channel USD Million (2023-2028)
  • Figure 41. South America Circle Acute Ischemic Stroke Share (%), by Country
  • Figure 42. Asia Pacific Circle Acute Ischemic Stroke Share (%), by Country
  • Figure 43. Europe Circle Acute Ischemic Stroke Share (%), by Country
  • Figure 44. MEA Circle Acute Ischemic Stroke Share (%), by Country
  • Figure 45. North America Circle Acute Ischemic Stroke Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Medtronic plc (Ireland)
  • Boston Scientific Corporation (United States)
  • Cordis Corporation (United States)
  • Koninklijke Philips N.V. (Netherlands)
  • GE Healthcare (United States)
  • Siemens AG (Germany)
  • Stryker Corporation (United States)
  • Genentech, Inc. (United States)
  • Merck & Co., Inc. (United States)
Select User Access Type

Key Highlights of Report


May 2023 206 Pages 56 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Circle Acute Ischemic Stroke Market Quantitative research analysis
Global Circle Acute Ischemic Stroke Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increased Prevalence of Acute Ischemic Stroke " is seen as one of major growth factors of Circle Acute Ischemic Stroke Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Circle Acute Ischemic Stroke market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Circle Acute Ischemic Stroke Market Report?

Have a Query? Click Here

Other Related Reports

Parasitic Diseases Therapeutic Comprehensive Study by Type (Antiprotozoal Therapeutics, Anthelminthic Therapeutics, Scabicides and Pediculicides Therapeutics), Application (Hospitals, Clinics, Homeca...
$ 3650
Cold Sore Treatment Comprehensive Study by Type (Non-Pharmacological Treatment, Pharmacological Treatment), Application (Hospitals, Homecare, Specialty Clinics, Others), Drug Type (Antiviral Ointment...
$ 3750
Superficial Radiation Therapy System Comprehensive Study by Type (External Beam Superficial Radiotherapy, Internal Superficial Radiotherapy), Application (Hospitals, Ambulatory Surgical Centers, Canc...
$ 3750
Meniere’s disease drug Comprehensive Study by Type (Classic, Vestibular, Bilateral), Application (Hospitals, Homecare, Specialty Clinics, Others), Drug Type (Meclizine, Diazepam, Prochlorperazine, Hy...
$ 3750
Biopuncture Treatment Comprehensive Study by Type (Homeopathic medicines, Vitamins and minerals, Plant extracts), Application (Gynecological Disorders, Psychological Disorders, Pain Syndrome illness,...
$ 3650
Immuno-oncology Assay Comprehensive Study by Type (Consumables, Software), Application (Research & Development, Clinical Diagnostics), Technology (Immunoassay, Flow Cytometry, PCR, Next-Generation Se...
$ 3650